Mosanna Therapeutics AG’s Seed Financing Round

Federica Tiefenthaler
Tagged:

VISCHER advised Mosanna Therapeutics AG on the deal.Mosanna Therapeutics AG, a Basel-based biotechnology company developing the advanced small molecule MOS118 (formerly know as AVE0118) for the…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

…

This content is for Standard 1 Year members only.
Login Join Now